104 related articles for article (PubMed ID: 11000062)
1. Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer.
Ayre SG; Garcia y Bellon DP; Garcia DP
Med Hypotheses; 2000 Oct; 55(4):330-4. PubMed ID: 11000062
[TBL] [Abstract][Full Text] [Related]
2. A new classification system of anticancer drugs - based on cell biological mechanisms.
Wu XZ
Med Hypotheses; 2006; 66(5):883-7. PubMed ID: 16414204
[TBL] [Abstract][Full Text] [Related]
3. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
4. Novel cytotoxic drugs: old challenges, new solutions.
Ismael GF; Rosa DD; Mano MS; Awada A
Cancer Treat Rev; 2008 Feb; 34(1):81-91. PubMed ID: 17905518
[TBL] [Abstract][Full Text] [Related]
5. Rationales for combining chemotherapy and biotherapy in the treatment of cancer.
Dillman RO
Mol Biother; 1990 Dec; 2(4):201-7. PubMed ID: 2288719
[TBL] [Abstract][Full Text] [Related]
6. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
Huq A; Singh B; Meeker T; Mascarenhas D
Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
[TBL] [Abstract][Full Text] [Related]
7. [Development of new antineoplastic agents: 10 years of active clinical research marked by the evolution of treatment, from an empirical to a rational approach].
Awada A
Bull Mem Acad R Med Belg; 2001; 156(6 Pt 2):338-47. PubMed ID: 11928224
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics.
Ríhová B; Kovár L; Kovár M; Hovorka O
Trends Biotechnol; 2009 Jan; 27(1):11-7. PubMed ID: 19022512
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
Shah MA; Schwartz GK
Clin Cancer Res; 2001 Aug; 7(8):2168-81. PubMed ID: 11489790
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound assistant chemotherapy may be a novel modality for solid tumors.
Pan H; Ma X; Li M; Chen J; Jiang H
Med Hypotheses; 2009 Oct; 73(4):526-7. PubMed ID: 19573996
[TBL] [Abstract][Full Text] [Related]
11. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy.
Kim R; Tanabe K; Uchida Y; Emi M; Inoue H; Toge T
Cancer Chemother Pharmacol; 2002 Nov; 50(5):343-52. PubMed ID: 12439591
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
Gotlieb WH; Bruchim I; Gu J; Shi Y; Camirand A; Blouin MJ; Zhao Y; Pollak MN
Gynecol Oncol; 2006 Feb; 100(2):389-96. PubMed ID: 16300820
[TBL] [Abstract][Full Text] [Related]
17. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
Hofmann F; García-Echeverría C
Drug Discov Today; 2005 Aug; 10(15):1041-7. PubMed ID: 16055020
[TBL] [Abstract][Full Text] [Related]
18. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
19. Curative and palliative aspects of regional chemotherapy in combination with surgery.
Müller H; Hilger R
Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.
Krieg AM
Oncogene; 2008 Jan; 27(2):161-7. PubMed ID: 18176597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
